Founded in 2010, Metronom Health is an early-stage medical device company, focusing on developing an innovative, opto-enzymatic continuous blood glucose monitoring technology for people living with diabetes. Metronom's proprietary technology is believed to provide very significant improvements over available Continuous Glucose Monitoring (CGM) technologies, in terms of accuracy in the hypo-glycemic range, reliability, user friendliness, with lower pricing to encourage broader adoption and easier insurance coverage. The company is now at a turning point in its short history, leveraging a sharp focus on engineering and R&D for development of a CGM product that supports the needs of users, as well as the people caring for them.
During the development process, Metronom recognized the critical role of metrology in both R&D and production quality control for its CGM.When working at a scale that is difficult to image with traditional microscopes, Metronom found that leading 3D optical metrology specialist ZYGO was able to provide the clarity that it is looking for, with features like 3D height mapping and resolution capabilities that were more quantitative and deterministic than traditional microscopes. Metronom also found that ZYGO’s metrology tools were a key enabling technology that helped to drive their product innovation by providing valuable process ad component information using data collection that was easily configurable and flexible.